2002/4/EC: Commission Decision of 27 December 2001 on financial assistance from the Community for storage in France, Italy and the United Kingdom of antigen for production of foot-and-mouth disease vaccine (notified under document number C(2001) 4383)
Date: 2001-12-27
Institutions: European Commission
Subjects: France, Italy, United Kingdom, foot-and-mouth disease, stock, vaccine

4.1.2002

EN

Official Journal of the European Communities

L 2/19

COMMISSION DECISION

of 27 December 2001

on financial assistance from the Community for storage in France, Italy and the United Kingdom of
antigen for production of foot-and-mouth disease vaccine

(notified under document number C(2001) 4383)

(2002/4/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(7)

Having regard to the Treaty establishing the European
Community,

Having regard to Council Decision 90/424/EEC of 26 June
1990 on expenditure in the veterinary field (1), as last amended
by Council Decision (EC) No 2001/572/EC (2), and in particular
Article 14 thereof,

Whereas:

(1)

(2)

(3)

(4)

(5)

By virtue of Council Decision 91/666/EEC of 11
December 1991 establishing Community reserves of
foot-and-mouth disease vaccines (3), as last amended by
Commission Decision 2001/181/EC (4), establishment of
antigen banks is part of the Community's action to
create Community reserves of foot-and-mouth disease
vaccines.

Article 3 of that Decision designates the ‘Laboratoire de
pathologie bovine du Centre national d'études vétéri-
naires et alimentaires’ at Lyon in France, which is now
part of the ‘Agence Française de Securite Sanitaire des
Aliments (AFSSA)’, and the ‘Istituto Zooprofilattico Sper-
imentale di Brescia’ in Italy, as the antigen banks holding
Community reserves, and provides for a procedure to
designate other establishments as antigen bank by
Commission Decision.

By Decision 2000/111/EC (5)
the Commission desig-
nated Merial S.A.S., Pirbright, United Kingdom, as a
third antigen bank.

The functions and duties of these antigen banks are
specified in Article 4 of Decision 91/666/EEC and
Community assistance must be conditional on accom-
plishment of these.

Community financial assistance should be granted to the
banks providing services to the Community to enable
them to carry out during 2001 the said functions and
duties.

(6)

For budgetary reasons the Community assistance should
be granted for a period of one year.

(1) OJ L 224, 18.8.1990, p. 19.
(2) OJ L 203, 28.7.2001, p. 16.
(3) OJ L 368, 31.12.1991, p. 21.
(4) OJ L 66, 8.3.2001, p. 39.
(5) OJ L 33, 8.2.2000, p. 21.

According to Article 3(2) of Council Regulation (EC) No
1258/1999 of 17 May 1999 on the financing of the
the
common agricultural policy (6), programmes for
eradication of animal diseases shall be financed under
the Guarantee Section of
financial
control purposes Articles 8 and 9 of this Regulation
apply.

the EAGGF;

for

(8)

(9)

The financial contribution of the Community shall be
granted to Member States provided that the authorities
supply all the necessary information within the time
limits set.

The measures provided for in this Decision are in
accordance with the opinion of the Standing Veterinary
Committee,

HAS ADOPTED THIS DECISION:

Article 1

The Community shall grant financial assistance to France
1.
for the stocking of antigen for the production of foot-and-
mouth disease vaccine.

2.
The ‘Agence Française de Securite Sanitaire des Aliments
(AFSSA)’ at Lyon in France shall hold the stock of antigen to
which paragraph 1 relates.

3.
The Community's financial assistance shall be up to a
maximum of EUR 30 000 for the period 1 January to 31
December 2001.

Article 2

1.
The Community shall grant financial assistance to Italy
for the stocking of antigen for the production of foot-and-
mouth disease vaccine.

2.
in
The ‘Istituto Zooprofilattico Sperimentale di Brescia’
Italy shall hold the stock of antigen to which paragraph 1
relates.

3.
The Community's financial assistance shall be up to a
maximum of EUR 30 000 for the period 1 January to 31
December 2001.

(6) OJ L 160, 26.6.1999, p. 103.

L 2/20

EN

Official Journal of the European Communities

4.1.2002

Article 3

The Community shall grant Merial S.A.S. Pirbright,
1.
United Kingdom,
the stocking of
financial assistance for
antigen for the production of foot-and-mouth disease vaccine.

2. Merial S.A.S. Pirbright, United Kingdom, shall hold the
stock of antigen stored at the premises of Merial S.A.S.
in
accordance with contracts SANCO/161/2000 and SANCO/
374/2000.

3.
The Community's financial assistance shall be up to a
maximum of EUR 26 100 for the periods 19 April 2001 to 31
December 2001 and 1 February 2001 to 31 December 2001
respectively.

Article 4

The Community's

financial assistance referred to in
1.
Article 1(3) and Article 2(3) shall be paid following the presen-
tation by the Member State concerned, and in the case of the
financial assistance referred to in Article 3(3) following the
presentation by Merial S.A.S., of supporting documents which
demonstrate the effective completion of the tasks.

The supporting documents referred to in paragraph 1
2.
must be presented to the Commission before 1 March 2002
and they shall

include:

(a) technical

information on:

— the amount and type of antigen stored (storage records),
— storage equipment used (type, number and capacity of

tanks),

— security systems in place (temperature control, anti-

theft measures),

— insurance arrangements (fire, accidents);

(b) financial information (completion of table as shown in the

Annex).

This Decision is addressed to the Member States.

Article 5

Done at Brussels, 27 December 2001.

For the Commission

David BYRNE

Member of the Commission

4.1.2002

EN

Official Journal of the European Communities

L 2/21

ANNEX